StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
7
Publishing Date
2023 - 02 - 27
1
2022 - 05 - 05
1
2022 - 02 - 25
1
2022 - 02 - 02
1
2022 - 01 - 24
1
2021 - 12 - 20
2
Sector
Health technology
7
N/a
1
Tags
Cancer
1
China
1
Collaboration
2
Earnings
3
Expansion
1
Financial
1
Financial results
1
Growth
1
Immunotherapy
2
License
1
Liver
1
Market
1
N/a
3
Novartis
3
Potential
1
Report
1
Research
1
Results
3
Sales
1
Therapy
2
Year
1
Entities
3m company
13
Abbott laboratories
119
Abbvie inc.
239
Abeona therapeutics inc.
7
Adaptimmune therapeutics plc
15
Alcon inc.
15
Alkermes plc
10
Amgen inc.
196
Astellas pharma inc
70
Astrazeneca plc
198
Autolus therapeutics plc
7
Bausch health companies inc.
74
Baxter international inc.
48
Becton, dickinson and company
19
Beigene, ltd.
7
Biogen inc.
54
Biontech se
10
Bluebird bio, inc.
11
Boston scientific corporation
17
Brainstorm cell therapeutics inc.
8
Bristol-myers squibb company
103
Csl ltd
9
Danaher corporation
11
Eli lilly and company
138
Endo international plc
20
General electric company
8
Genmab a/s
21
Gilead sciences, inc.
28
Glaxosmithkline plc
304
Grifols sa
10
Incyte corporation
21
Ionis pharmaceuticals, inc.
9
Jazz pharmaceuticals plc
14
Johnson & johnson
245
Koninklijke philips n.v.
19
Mallinckrodt plc
17
Medtronic plc
36
Morphosys ag
15
Novartis ag
1241
Novo nordisk a/s
28
Orange
8
Orchard therapeutics plc
9
Perrigo company
8
Pfizer, inc.
88
Precision biosciences, inc.
8
Reckitt benckiser group plc
9
Regeneron pharmaceuticals, inc.
13
Regenxbio inc.
12
Sanofi
329
Stryker corporation
12
Takeda pharmaceutical company limited
58
Terumo corp
9
Teva pharmaceutical industries limited
9
Teva pharmaceutical industries ltd
206
Thermo fisher scientific inc
51
Ucb s.a.
8
Uniqure n.v.
12
Vericel corporation
8
Viatris inc.
120
Xencor, inc.
11
Symbols
ABBV
11
ADAP
2
ADCT
5
AGIO
10
ALNY
10
ALPMF
1
ALPMY
1
AMGN
117
ASMB
1
ATLX
1
ATLXD
1
AVEO
10
AZN
2
BCEL
1
BEIGF
117
BGNE
323
BIIB
1
BMIX
1
BMY
12
BPMC
10
CCXI
50
CDXS
1
CLSD
1
CLVS
10
CTMX
1
DNAA
1
EPZM
10
EXAS
1
EXEL
10
FNCTF
2
FUTU
1
GILD
1
HCM
7
HZNP
1
ILMN
10
INCY
12
JAZZ
12
JNJ
3
KPTI
11
KRTX
2
LEGN
1
LLY
19
LPTX
35
MS
5
NVS
7
NVSEF
7
PFE
10
RARE
2
REGN
15
RIGL
10
SNY
18
SNYNF
8
SWTX
4
TARA
2
VOR
2
VSTM
10
XNCR
6
YMAB
10
ZEAL
2
ZYME
54
Exchanges
Nasdaq
7
Nyse
7
Crawled Date
2023 - 02 - 27
1
2022 - 05 - 05
1
2022 - 02 - 25
1
2022 - 02 - 02
1
2022 - 01 - 24
1
2021 - 12 - 20
2
Crawled Time
07:00
1
12:00
1
12:30
2
14:00
1
17:00
1
23:00
1
Source
www.biospace.com
4
www.globenewswire.com
2
www.prnewswire.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
entities :
Beigene, ltd.
symbols :
NVS
save search
BeiGene Reports Fourth Quarter and Full Year 2022 Financial Results
Published:
2023-02-27
(Crawled : 14:00)
- biospace.com/
NVS
|
$93.08
-0.13%
0.86%
1.2M
|
Health Technology
|
8.41%
|
O:
0.64%
H:
0.01%
C:
-0.72%
BGNE
S
|
$131.885
-1.62%
-1.64%
200K
|
Health Technology
|
-37.82%
|
O:
-2.82%
H:
5.13%
C:
3.11%
year
financial
results
BeiGene Reports First Quarter 2022 Financial Results
Published:
2022-05-05
(Crawled : 12:00)
- biospace.com/
NVS
|
$93.08
-0.13%
0.86%
1.2M
|
Health Technology
|
6.1%
|
O:
-0.39%
H:
0.15%
C:
-1.07%
BGNE
S
|
$131.885
-1.62%
-1.64%
200K
|
Health Technology
|
-16.9%
|
O:
0.98%
H:
7.7%
C:
-2.09%
results
BeiGene Reports Fourth Quarter and Full Year 2021 Financial Results
Published:
2022-02-25
(Crawled : 12:30)
- biospace.com/
ZYME
|
$8.86
-0.78%
-0.79%
370K
|
Health Technology
|
24.03%
|
O:
2.5%
H:
0.0%
C:
0.0%
NVS
|
$93.08
-0.13%
0.86%
1.2M
|
Health Technology
|
8.33%
|
O:
1.04%
H:
0.0%
C:
0.0%
BGNE
S
|
$131.885
-1.62%
-1.64%
200K
|
Health Technology
|
-37.89%
|
O:
1.12%
H:
0.0%
C:
0.0%
financial results
report
results
Novartis delivers mid single digit sales growth, margin expansion and advancement of robust pipeline in 2021
Published:
2022-02-02
(Crawled : 07:00)
- globenewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
7.11%
|
O:
-1.53%
H:
0.0%
C:
-0.64%
NVS
|
$93.08
-0.13%
0.86%
1.2M
|
Health Technology
|
5.36%
|
O:
-3.38%
H:
0.0%
C:
0.0%
BGNE
S
|
$131.885
-1.62%
-1.64%
200K
|
Health Technology
|
-44.41%
|
O:
6.32%
H:
0.0%
C:
0.0%
sales
novartis
expansion
liver
growth
Billions Flowing into Cancer Immunotherapy as Market Responds to Impressive Market Potential
Published:
2022-01-24
(Crawled : 17:00)
- prnewswire.com
SNYNF
|
$92.116
-2.18%
2.3K
|
Health Technology
|
-11.36%
|
O:
-1.92%
H:
0.0%
C:
-1.88%
NVS
|
$93.08
-0.13%
0.86%
1.2M
|
Health Technology
|
5.68%
|
O:
-3.71%
H:
0.66%
C:
0.66%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-12.0%
|
O:
-2.45%
H:
0.18%
C:
-0.02%
ONCY
|
$1.045
-3.24%
-3.35%
180K
|
Health Technology
|
-42.41%
|
O:
-1.05%
H:
1.59%
C:
-3.17%
EXAS
|
$63.21
-1.02%
-1.03%
2.5M
|
Health Technology
|
-13.74%
|
O:
-2.0%
H:
3.27%
C:
2.91%
BGNE
S
|
$131.885
-1.62%
-1.64%
200K
|
Health Technology
|
-46.69%
|
O:
-2.95%
H:
2.45%
C:
1.98%
immunotherapy
potential
therapy
cancer
market
Novartis strengthens immunotherapy pipeline with option, collaboration and license agreement with BeiGene for TIGIT inhibitor ociperlimab
Published:
2021-12-20
(Crawled : 23:00)
- globenewswire.com
NVS
|
$93.08
-0.13%
0.86%
1.2M
|
Health Technology
|
7.47%
|
O:
-1.03%
H:
0.24%
C:
-0.15%
BGNE
S
|
$131.885
-1.62%
-1.64%
200K
|
Health Technology
|
-48.93%
|
O:
8.83%
H:
0.11%
C:
-4.16%
novartis
license
immunotherapy
therapy
collaboration
BeiGene Expands Collaboration with Novartis to Develop and Commercialize BeiGene’s TIGIT Inhibitor and Market Five Novartis Oncology Medicines in China Broad Markets
Published:
2021-12-20
(Crawled : 12:30)
- biospace.com/
NVS
|
$93.08
-0.13%
0.86%
1.2M
|
Health Technology
|
7.47%
|
O:
-1.03%
H:
0.24%
C:
-0.15%
BGNE
S
|
$131.885
-1.62%
-1.64%
200K
|
Health Technology
|
-48.93%
|
O:
8.83%
H:
0.11%
C:
-4.16%
novartis
china
collaboration
Gainers vs Losers
57%
43%
Top 10 Gainers
INVO
|
$1.76
131.58%
56.82%
230M
|
Health Technology
SINT
|
$0.0365
59.39%
37.26%
470M
|
Health Technology
WISA
4
|
$9.19
50.66%
33.7%
65M
|
Electronic Technology
EDBL
|
$6.73
47.91%
32.39%
13M
|
GCTK
|
$0.715
36.27%
26.62%
640K
|
Manufacturing
TCON
|
$2.33
36.26%
26.61%
1.9M
|
Health Technology
TIRX
|
$0.48
6.43%
24.58%
800K
|
KZIA
|
$0.38
30.58%
23.42%
300K
|
Health Technology
VNDA
|
$5.23
29.14%
22.56%
24M
|
Health Technology
ATNF
|
$1.91
29.05%
22.51%
310K
|
Your saved searches
Save your searches and get alerts when important news are released.